HU0300203A3 - Novel cyclic amide derivatives, and pharmaceutical compositions containing same - Google Patents

Novel cyclic amide derivatives, and pharmaceutical compositions containing same

Info

Publication number
HU0300203A3
HU0300203A3 HU0300203A HU0300203A HU0300203A3 HU 0300203 A3 HU0300203 A3 HU 0300203A3 HU 0300203 A HU0300203 A HU 0300203A HU 0300203 A HU0300203 A HU 0300203A HU 0300203 A3 HU0300203 A3 HU 0300203A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
compositions containing
amide derivatives
containing same
cyclic amide
Prior art date
Application number
HU0300203A
Other versions
HU0300203A2 (en
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2000054674 priority Critical
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Priority to PCT/JP2001/001413 priority patent/WO2001064670A1/en
Publication of HU0300203A2 publication Critical patent/HU0300203A2/en
Publication of HU0300203A3 publication Critical patent/HU0300203A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
HU0300203A 2000-02-29 2001-02-26 Novel cyclic amide derivatives, and pharmaceutical compositions containing same HU0300203A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2000054674 2000-02-29
PCT/JP2001/001413 WO2001064670A1 (en) 2000-02-29 2001-02-26 Novel cyclic amide derivatives

Publications (2)

Publication Number Publication Date
HU0300203A2 HU0300203A2 (en) 2003-05-28
HU0300203A3 true HU0300203A3 (en) 2006-01-30

Family

ID=18575896

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300203A HU0300203A3 (en) 2000-02-29 2001-02-26 Novel cyclic amide derivatives, and pharmaceutical compositions containing same

Country Status (17)

Country Link
US (1) US7166617B2 (en)
EP (1) EP1260512B1 (en)
JP (1) JP4859324B2 (en)
CN (1) CN100384836C (en)
AT (1) AT366249T (en)
AU (2) AU3417501A (en)
CA (1) CA2401711C (en)
DE (1) DE60129210T2 (en)
DK (1) DK1260512T3 (en)
ES (1) ES2291293T3 (en)
HU (1) HU0300203A3 (en)
IL (2) IL151533D0 (en)
NZ (1) NZ521576A (en)
PT (1) PT1260512E (en)
RU (1) RU2257384C2 (en)
TW (1) TWI296625B (en)
WO (1) WO2001064670A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550459B2 (en) 2001-12-28 2009-06-23 Acadia Pharmaceuticals, Inc. Tetrahydroquinoline analogues as muscarinic agonists
AT304533T (en) 2001-12-28 2005-09-15 Acadia Pharm Inc Tetrahydroquinoline as a muscarinic agonist
EP1680408A2 (en) * 2003-10-24 2006-07-19 F. Hoffmann-La Roche Ag Ccr3 receptor antagonists
US20060019969A1 (en) * 2004-07-24 2006-01-26 Laboratorios Dr. Esteve S.A. Use of compounds active on the sigma receptor for the treatment of allodynia
US7807706B2 (en) * 2005-08-12 2010-10-05 Astrazeneca Ab Metabotropic glutamate-receptor-potentiating isoindolones
US7868008B2 (en) * 2005-08-12 2011-01-11 Astrazeneca Ab Substituted isoindolones and their use as metabotropic glutamate receptor potentiators
WO2007021308A1 (en) * 2005-08-12 2007-02-22 Astrazeneca Ab Metabotropic glutamate-receptor-potentiating isoindolones
US8329694B2 (en) 2005-06-24 2012-12-11 Toyama Chemical Co., Ltd. Quinoxalinones as antibacterial composition
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
TW200804281A (en) * 2006-02-16 2008-01-16 Astrazeneca Ab New metabotropic glutamate receptor-potentiating isoindolones
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536667A (en) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド 5ht receptor-mediated neurogenesis
US7998971B2 (en) * 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
CN101186612B (en) * 2006-11-15 2012-10-03 天津和美生物技术有限公司 Pyrroline derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application
EP2114166A4 (en) * 2006-12-11 2011-05-25 Reviva Pharmaceuticals Inc Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
TWI417100B (en) * 2007-06-07 2013-12-01 Astrazeneca Ab Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators-842
WO2009010479A2 (en) * 2007-07-13 2009-01-22 Euroscreen S.A. Heterocyclic methylene piperidine derivatives and their use
DE102007047737A1 (en) * 2007-10-05 2009-04-30 Merck Patent Gmbh Piperidine and piperazine derivatives
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
US7790760B2 (en) * 2008-06-06 2010-09-07 Astrazeneca Ab Metabotropic glutamate receptor isoxazole ligands and their use as potentiators 286
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2353591A1 (en) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
ES2656313T3 (en) * 2010-07-20 2018-02-26 Minerva Neurosciences, Inc. Use of cyclic amide derivatives to treat sleep disorders
RU2613201C2 (en) * 2010-07-20 2017-03-15 Сиренейк Фармасьютикалз Инк. Methods of using cyclic amide derivatives for treating sigma-receptor mediated disorders
US8937900B2 (en) 2010-07-20 2015-01-20 Qualcomm Incorporated Enhancing pilot channel transmission in TD-SCDMA multicarrier systems using secondary carrier frequencies
EP2415471A1 (en) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in opioid-induced hyperalgesia
EP2524694A1 (en) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Use of sigma ligands in diabetes type-2 associated pain
CN103524515B (en) * 2012-07-03 2016-07-06 浙江海正药业股份有限公司 Having acetylcholinesterase inhibitory dioxole derivatives and their preparation and use inter-benzo activity
JP2016540771A (en) 2013-12-17 2016-12-28 ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ Combination of serotonin-noradrenaline reuptake inhibitor (SNRI) and sigma receptor ligand
US10179776B2 (en) * 2014-06-09 2019-01-15 Intra-Cellular Therapies, Inc. Compounds and methods of use to treat schizophrenia
MX2017007065A (en) * 2014-12-02 2017-12-18 Minerva Neurosciences Inc Compositions comprising 2-((1-(2(4-fluorophenyl)-2-oxoethyl)piper idin-4-yl)methyl)isoindolin-1-one for treating schizophrenia.
US10238632B2 (en) 2015-06-11 2019-03-26 Fujifilm Toyama Chemical Co., Ltd. Sigma receptor-binding agent
CN105523939B (en) * 2015-12-30 2017-11-14 李函璞 A process for preparing intermediates to lenalidomide
TW201808288A (en) 2016-05-25 2018-03-16 田邊三菱製藥股份有限公司 Compositions and methods for treating negative symptoms in non-schizophrenic patients
US20190038561A1 (en) 2017-06-21 2019-02-07 Minerva Neurosciences, Inc. Gastro-resistant controlled release oral dosage forms

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3742951B1 (en) * 1971-08-09 1982-11-23
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3947578A (en) * 1972-07-28 1976-03-30 Roussel Uclaf Omega-[4-(3"-indolyl)-piperidino]-alkyl-arylketones as nevroleptics
US3921636A (en) * 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US4000287A (en) * 1974-12-16 1976-12-28 Ciba-Geigy Corporation Isoindolinopiperidines
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4062953A (en) * 1976-06-24 1977-12-13 E. R. Squibb & Sons, Inc. Various 2-substituted-1H-benz[de]isoquinoline-1,3(2H)-diones
US4168315B1 (en) * 1977-09-28 1985-05-28
US4495194A (en) * 1982-11-12 1985-01-22 Mead Johnson & Company Antihypertensive isoindole derivatives
US5169096A (en) * 1985-07-02 1992-12-08 Merrell Dow Pharmaceuticals Inc. N-aralkyl-piperidine-methanol derivatives
US4783471A (en) * 1985-07-02 1988-11-08 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine methanol derivatives and the uses thereof
US4912117A (en) * 1985-07-02 1990-03-27 Merrell Dow Pharmaceuticals Inc. Novel chemical compounds
US5021428A (en) * 1985-07-02 1991-06-04 Merrell Dow Pharmaceuticals Inc. Novel chemical compounds for the prophylactic treatment of migraine
US4762842A (en) * 1985-10-01 1988-08-09 Eli Lilly And Company Selective method for blocking 5HT2 receptors
AU593194B2 (en) * 1986-09-26 1990-02-01 Sumitomo Pharmaceuticals Company, Limited Imide derivatives ,and their production and use
DE3855287T2 (en) * 1987-06-26 1996-12-05 Hitachi Ltd A superconducting wire
US4877798A (en) * 1987-11-23 1989-10-31 Merrell Dow Pharmaceuticals Inc. Treatment of fibromyalgia
US5093341A (en) 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
US5166211A (en) * 1987-12-17 1992-11-24 Merrell Dow Pharmaceuticals Inc. Method of using 1,4-disubstituted piperidinyl compounds in the treatment of coronary vasospasons and variant angina
DE3888340D1 (en) * 1988-01-21 1994-04-14 Merrell Dow Pharma Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia.
EP0339342A1 (en) * 1988-04-23 1989-11-02 Bayer Ag N-substituted N-amino pyrroles
US5182399A (en) * 1988-10-13 1993-01-26 Merrell Dow Pharmaceuticals Inc. Process for preparing piperidinyl benzimidazoles
US4908372A (en) * 1988-10-13 1990-03-13 Merrell Dow Pharmaceuticals Inc. Antihistaminic piperidinyl benzimidazoles
FR2641278B1 (en) * 1989-01-05 1991-03-22 Lipha Piperidines, preparation processes and drugs containing
US5356906A (en) * 1989-10-27 1994-10-18 The Du Pont Merck Pharmaceutical Company (N-phthalimidoalkyl) piperidines useful as treatments for psychosis
ZA9008641B (en) * 1989-10-27 1992-06-24 Du Pont (n-phthalimidoalkyl)piperidines
US5106855A (en) * 1989-12-20 1992-04-21 Merrell Dow Pharmaceuticals Inc. Method for the treatment of glaucoma
US5292752A (en) * 1989-12-21 1994-03-08 Merrell Dow Pharmaceuticals Inc. Antithrombotic compounds
WO1991018602A1 (en) * 1990-06-01 1991-12-12 Merrell Dow Pharmaceuticals Inc. (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
AT145208T (en) * 1990-07-06 1996-11-15 Yoshitomi Pharmaceutical Fused thiophene compounds and their use
CA2097317C (en) * 1990-12-14 2002-02-12 Albert A. Carr Antiallergic piperdinyl benzimidazoles
US5231099A (en) * 1991-04-15 1993-07-27 Du Pont Merck Pharmaceutical Company Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs
DE69330823T2 (en) * 1992-02-13 2002-05-02 Merrell Pharma Inc thiacyclic piperidinyl derivatives
AU5923398A (en) 1997-01-21 1998-08-07 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
DE19905823C1 (en) 1999-02-12 2000-06-08 Deutsches Krebsforsch Collimator for high energy radiation, e.g. for the treatment of tumors, comprises numerous opposing scree sections made of radiation absorbing material
AU3899600A (en) 1999-03-18 2000-10-04 Incyte Pharmaceuticals, Inc. Regulators of intracellular phosphorylation

Also Published As

Publication number Publication date
AU2001234175B2 (en) 2004-10-07
NZ521576A (en) 2005-06-24
EP1260512A4 (en) 2005-07-13
CA2401711C (en) 2008-06-03
IL151533A (en) 2008-03-20
EP1260512B1 (en) 2007-07-04
WO2001064670A1 (en) 2001-09-07
PT1260512E (en) 2007-10-10
AT366249T (en) 2007-07-15
RU2257384C2 (en) 2005-07-27
US20030212094A1 (en) 2003-11-13
HU0300203A2 (en) 2003-05-28
JP4859324B2 (en) 2012-01-25
CA2401711A1 (en) 2001-09-07
CN1426405A (en) 2003-06-25
DE60129210D1 (en) 2007-08-16
CN100384836C (en) 2008-04-30
ES2291293T3 (en) 2008-03-01
EP1260512A1 (en) 2002-11-27
US7166617B2 (en) 2007-01-23
DK1260512T3 (en) 2007-11-05
DE60129210T2 (en) 2008-03-20
IL151533D0 (en) 2003-04-10
TWI296625B (en) 2008-05-11
AU3417501A (en) 2001-09-12

Similar Documents

Publication Publication Date Title
EG24357A (en) New Pharmaceutical composition
GB2358582B (en) Pharmaceutical compositions
TWI293305B (en) Glucopyranosyloxybenzylbenzene derivatives, pharmaceutical compositions comprising the same and intermediates thereof
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
IL148361D0 (en) Benzylidene-thiazolidinedione derivatives and pharmaceutical compositions containing the same
IL157731D0 (en) Caboxylic acid derivatives and pharmaceutical compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
HUS1400025I1 (en) Phenethanolamine derivatives and pharmaceutical composition containing them
IL154981D0 (en) Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppay-y-binding agents
IL175614D0 (en) Cyclic amine derivatives having a heteroaryl ring and pharmaceutical compositions containing the same
IL155071D0 (en) Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same
HU0301169A3 (en) 9-substituted minocycline derivatives, pharmaceutical compositions containing them and their use
IL158041D0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
HK1057369A1 (en) C2-phenyl-substituted cyclic keto-enols used as pessticides and herbicides
IL158523D0 (en) Epothilone derivatives and pharmaceutical compositions containing the same
IL156751A (en) Substituted alkylamine derivatives and pharmaceutical compositions thereof
IL164987A (en) Proline derivatives and pharmaceutical compositions containing the same
HU0300582A3 (en) Pharmaceutical compositions
IL148384D0 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
PL195633B1 (en) Piperidine derivatives, their use and pharmaceutical compositions comprising them
IL173602D0 (en) Heteroarylaminosulfonylphenyl derivatives and pharmaceutical compositions containing the same
IL173627D0 (en) 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives and pharmaceutical compositions containing the same
IL152490D0 (en) Pyridine derivatives and pharmaceutical compositions containing the same
HU0202254A3 (en) Amide substituted imidazoquinolines and pharmaceutical compositions containing them